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ABSTRACT  In this report we characterize muscarinic cholinergic receptor on embryonic cells. 
We  established dose-response curves  by fluorometric  measurement of Ca  2+ mobilization  in 
cell suspensions of whole chick embryos stage 23•24.  Ca  2+ mobilization  was quantitated  by 
standardization of chlorotetracycline  (CTC) fluorescence changes after stimulation with mus- 
carinic agonists. We determined  EDso values for the agonists acetylcholine and carbachol as 
3.4 x  10  -6 and 2.7 ×  10  -5 M, respectively.  Pilocarpine and oxotremorine were found to act 
as reversible  competitive  antagonists with  inhibition  constants (K0 of 5.0 x  10  -6 and  1.4  x 
10  -6 M,  respectively.  Bethanechol, which  induced only 23% of the maximal  effect obtained 
by acetylcholine, was a partial agonist with an EDso of 4.8 x  10  -4 M. Its antagonistic component 
is  expressed  by  an  inhibition  constant  of  1.9  x  10  -4  M.  In  parallel,  binding  studies  were 
performed in a competition assay with [3H]-quinuclidinylbenzilate.  For the agonists acetylcho- 
line  and  carbachol,  binding  parameters  were  best  fitted  by  a  "two  binding-sites  model." 
Comparison with dose-response curves indicated that Ca  2÷ mobilization was triggered via the 
high-affinity  binding  site.  The  inhibition  constants  of antagonists derived  from  the  shift  of 
dose-response curves corresponded to the fitted KD values of the binding studies when a "one 
binding-site  model"  was applied.  Combination  of dose-response and  binding data  showed 
close proportionality between receptor occupancy and calcium mobilization.  No spare recep- 
tors were present. 
Undifferentiated  cells of the chick limb bud possess a  mus- 
carinic cholinergic receptor (1) which is assumed to be part 
of an embryonic cholinergic system that is expressed in un- 
differentiated  cells during  distinct  phases  of morphogenesis 
(2,  3).  In a  preceding publication, we described intracellular 
Ca  2÷ mobilization upon stimulation of the receptor (4).  Ca  2* 
mobilization  was  measured  in  a  spectrofluorometric  assay 
with chlorotetracycline (CTC) 1 (5,  6). On addition of musca- 
rinic  agonists,  the  cells  responded  with  a  fluorescence  de- 
crease. The reaction was blocked by muscarinic antagonists. 
Nicotinic drugs were ineffective. 
For further characterization of the muscarinic receptor on 
embryonic cells,  dose-response curves have to be established. 
Abbreviations  used in this paper:  B~, total concentration  of spe- 
cific binding  sites; CTC, chlorotetracycline;  cv, coefficient of varia- 
tion;  ED~o, the agonist concentration  that yields 50%  of maximal 
effect; MSE, mean square error; QNB, quinuclidinylbenzilate. 
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Intracellular Ca  2+ mobilization is a biological effect that can 
be  used  for this  purpose.  In the  present  study,  to quantify 
CTC fluorescence changes, we standardized the fluorometric 
measurements and  improved data  processing.  The dose-re- 
sponse curves have to be related to receptor occupancy. Since 
ligand affinities in homogenate are different from those in cell 
suspensions,  our binding data from homogenate (1) cannot 
be used for discussion of dose-response curves. In particular, 
binding of muscarinic agonists in homogenate is influenced 
by incubation conditions (7) and concentration of metabolites 
such as guanosine triphosphate (8).  Therefore, in the present 
study,  we determined  binding of muscarinic  ligands  in  cell 
suspensions in parallel to the fluorometric measurements.  A 
binding  assay  with  [3H]-quinuclidinylbenzilate  (QNB)  was 
established.  Instead of the filter assay used for homogenate, 
we separated bound and free radioactivity by centrifugation. 
In contrast to the previous study in  which cell suspensions 
from chick limb buds of stage 23/24 were used, we isolated 
1073 the cells from whole embryos stage 23/24  in order to obtain 
the large numbers of cells necessary for serial measurements. 
MATERIALS  AND  METHODS 
Drugs and Chemicals:  Enzymes  and Dulbecco's modified Eagle's 
medium (NaHCOs omitted, 20 mM HEPES supplemented) were provided by 
Boehringer GmbH (Mannheim, Federal Republic of Germany [FRG]). The 
other chemicals were purchased from the following sources: tritium-labeled 
(32 Ci/mmol) and unlabeled QNB (Radiochemical Centre, Amersham, U.K.), 
atropine sulfate (Merck AG, Darmstadt, FRG), pirenzepine dihydrochloride 
(Thomae, Biberach, FRG), acetylcholine chloride, bethanechol chloride, oxo- 
tremorine, carbachol chloride (carbamylcholine chloride), piJocarpine hydro- 
chloride, chlorotetracycline hydrochloride, and physostigmine sulfate (Sigma 
Chemie GmbH, Miinchen, FRG). Dexetimide and Jevetimide are gifts from 
Janssen GmbH (Neuss-Rosellen, FRG). 
Fluorometric Measurements:  Cell  suspensions of whole chick em- 
bryos stage 23/24  were prepared by enzymatic digestion according to the 
procedure outlined in a previous publication (4). Cells were stored up to 5 h in 
tissue culture medium (Dulbecco's modified Eagle's medium). Before loading 
the cells with CTC, we transferred them into Hanks' solution ( 1.26 mM Ca  2.) 
without NaHCOs that contained 20 mM HEPES, pH 7.3, at 37"C. For dose- 
response curves, up to five  matched probes were prepared from a single batch 
of cells. The cell suspensions were prestained with CTC (20 gM) in a roller 
culture apparatus (six turns per minute) at 37"C for 20 min.  Fluorometric 
measurements were performed in a Yobin Yvon spectrofluorometer  JY 3 D as 
described previously (4). In experiments using acetylcholine for stimulation, 
physostigmine (1 uM) was added before stimulation. 
Binding Assay:  Ligand  binding in cell suspension was measured by a 
centrifugation assay using [SH]QNB as the specific  ligand for muscarinic binding 
sites. Two incubations with a total volume of 1,100 ul each were prepared, the 
first (incubation 1  ) containing [3H]QNB (0.4 nM) alone, the second (incubation 
2) containing [3H]QNB (0.4 nM) and radioinert atropine in excess (1  tam). 
Reagents and  cell suspensions were prepared  in  Hanks'  solution without 
NaHCO3 containing 20 mM HEPES, pH 7.3, at 37"C.  Cell concentration varied 
between 5 x  106 and 9 x  l& cells/ml (molar concentrations of specific  binding 
sites [B=,~] between 30 and 60 pM). Incubation was performed in Eppendorf 
microvials in a shaking water bath (37"C, 75  cycles per minute). After an 
incubation period of 1.5 h,  free and bound radioactivity were separated by 
centrifugation for l rain at 7,000 g in an "Eppendorf centrifuge 5414." Kinetic 
experiments revealed that 1.5 h are sufficient  to reach equilibrium. The super- 
natant  was pipetted carefully into  a  scintillation vial containing  15  ml of 
scintillation fluid (UNISOLVE 1, Zinsser, Frankfurt, FRG). Residuals of su- 
pernatant were removed by superficial washing with 200 tal Hanks' solution 
(0*C) and added to the scintillation vial. Preliminary experiments showed that 
at 0*C no measurable dissociation of bound [3H]QNB occurred during the 
washing procedure. The sediment was resuspended in 200 tal Hanks' solution 
and transferred to a second scintillation vial with 10 ml of scintillator. Incu- 
bation cups were washed twice with 200 tal Hanks' solution, the washing being 
added to the scintillation vial. Radioactivity was counted in a Beckman beta- 
counter (LS 9800) (Beckman Instruments, Inc., Palo Alto, CA). Counting 
efficiencies  were estimated by external standard (40-43% for supernatants and 
42-45% for sediments). 
DATA ANALYSIS 
Standardization of CTC Fluorescence  Changes 
Cells were stimulated by adding the drug in a small volume 
(AV=  10 ul) of stem solution to the CTC-stained cell suspen- 
sion  (VT  =  2  ml).  The  decline  (2dr)  of total  fluorescence 
intensity  (Ix)  was  due  to  the  pharmacological  effect of the 
drug (A/biol)  and a  dilution effect (A/vo0. The constant a  was 
measured (a =  0.7). 
AI~o,/IT =  -a. A V/VT.  (1) 
AIt,ioJ =  Z2t/T +  oZ.IT.AV/VT.  (2) 
For standardization,  A/biot is expressed  in  percentage  of the 
fluorescence of CTC-stained cells (Le,).  L,,  is the difference 
between the total fluorescence of the CTC-stained cell suspen- 
sion (IT) before stimulation  and background  fluorescence of 
the CTC-containing medium without cells (I~). lbg was deter- 
mined after removal of cells by centrifugation, 
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Lo,,  =  h  -  I~.  (3) 
~Is,~.d = MbJlce,.  (4) 
Calculation of Specific  Binding 
Separation  of cell-bound  and  free  radioactivity  was  per- 
formed  by  rapid  centrifugation.  Since during centrifugation 
cells  are  in  continuous  contact  with  the  supernatant,  the 
equilibrium between bound and free ligands was maintained 
during separation.  Thus the measured values reflect the true 
equilibrium  concentrations  of free  and  bound  radiolabeled 
ligand in the incubations:  Free radioactivities were measured 
in  the  supernatants  of incubation  1  (F0  and  incubation  2 
(F2), and bound  radioactivities were measured in the respec- 
tive sediments  (B~  and  B2).  Usually specific binding  is esti- 
mated by the difference of bound radioactivity in both incu- 
bations: 
D  =  Bt  -  B2.  (5) 
In the present study we calculated specific binding as follows: 
Dco~ = B~  -  B2.Fj/F2  (6) 
This formula corrects for systematic underestimation  of spe- 
cific binding  by  Eq.  5:  in  incubation  2,  total  radioactivity 
contributes  to  free  and  nonspecifically  bound  radioactivity 
whereas  in  incubation  1  a  fraction  of the  radioactivity  is 
specifically bound.  In  the  standard  incubations  (5-9  ×  106 
cells/ml), 20-50  pM of total [3H]QNB (400 pM) was bound 
specifically and 20-40 pM was bound nonspecifically. There- 
fore,  F~  <  F2  and  the  values  of the  correction  term  FJFz 
range between 0.86 and 0.95. 
Parameter  Fitting 
For parameter  fitting we used the nonlinear least squares 
regression  program  BMDPAR  (BMDP  statistical  software, 
University of California,  1981) on a  UNIVAC  1100/80 com- 
puter  (Rechenzentrum  der  Universitht  Tiibingen).  Confi- 
dence limits were computed as "asymptotic standard  devia- 
tions" (BMDP manual,  1981). Concentrations were internally 
transformed  to  logarithms prior to  fitting.  Therefore,  confi- 
dence  limits  of parameters  with  the dimension  "concentra- 
tion" (e.g., dissociation constants)  sometimes appear unsym- 
metrical. The goodness of fit of different models to the same 
data can be compared by the mean square error (MSE) of the 
fits. The MSE of a fit is equal to the minimal residual sum of 
squares divided by (n  -  p),  where  n  is the number  of cases 
and p  is the number of independent parameters.  Most of the 
figures,  including  the  fitted  curves,  were  plotted  with  the 
DISSPLA software system (Integrated  Software Systems Co- 
operation,  San Diego, CA) on a  Calcomp plotter connected 
to the UNIVAC  1100/80. 
Dose-Response  Curves 
Parameters were fitted by assuming one class of noninter- 
acting receptors and proportionality between occupancy and 
effect (9). 
Alst~,d =  Almax" [A]/(EDso +  [A]),  (7) 
where AIs~,d, the standardized  fluorescence decrease (Eq. 4), 
is the dependent  variable and the agonist concentration  [A] 
is the independent variable. The parameter A/m~, signifies the 
maximal effect and EDso is the agonist concentration yielding 
50% of maximal effect. Addition of a reversible competitive antagonist (I) before 
stimulation resulted in a shift of the dose-response curve to 
the right (see Fig. 3). From EDso values of shifted (EDso') and 
unshifted  (EDso)  curves,  the  KI  value  of the  antagonistic 
substance can be calculated. Under the assumptions of  Clark's 
model (9), K~ is identical to the dissociation constant of the 
antagonist (10): 
KI =  [I].EDso/(EDso' -  ED~o).  (8) 
Saturation Studies 
Specific binding of [3H]QNB was nonlinearily fitted to the 
saturation function (9) of a "one-site model" with the para- 
meters Bmax  (total concentration of specific binding sites) and 
KD (dissociation constant): 
[R-3HQ]  =  Bmax"  [3HQ]/(KD +  [3HQ]).  (9) 
[3HQ],  the  equilibrium  concentration of free [3H]QNB,  is 
measured  as  F,  in  the  supernatant  of incubation  1,  and 
[R-3HQ], the equilibrium concentration of specifically bound 
[3H]QNB, is calculated as D¢or~  according to Eq~ 6. 
Competition Curves 
The data input of one competition experiment consisted of 
12 triplets of values:  [A], [3HQ], and [R-3HQ].  The concen- 
tration of competitor A was known and [3HQ] and [R-3HQ] 
were measured as F,  and /)corr. We avoided systematic and 
random errors due to various concentrations of total and free 
[3H]QNB  in  the  individual  incubations  by  measuring  the 
concentration of free [3H]QNB individually in each incuba- 
tion. Competition data were fitted to three models: The first 
model assumes the competition of [3H]QNB and an unlabeled 
ligand (A) for a single population of noninteracting binding 
sites (one-site model): 
B,.,,.. [3HQ] 
[R'3HQ]  -- KQ +  [3HQ]  +  [A].Ko/KA"  (10) 
KQ (the dissociation constant of [3H]QNB derived from satu- 
ration studies) has a  fixed value (KQ =  KD =  10  -l° M; see 
Table III).  [A] is the concentration of competitor and KA is 
its dissociation constant. The fitting procedure creates values 
for the free parameters Bmax and KA. 
The second model describes the displacement of [3H]QNB 
by  unlabeled  ligand  which  has  different affinities for two 
noninteracting sites (two-sites  model): 
[R.3HQ  ] =  RH. [3HQ] 
KQ +  [3HQ] +  [A]- KQ/Kn  ( 1 l) 
RL" [3HQ]  + 
KQ +  [3HQ]  +  [A].Ko/K  L" 
Parameter estimates were created for the concentrations of 
binding sites showing high affinity (RH) and low affinity (RE) 
towards the competitor and  for the  respective dissociation 
constants KH and KL. 
The third model is derived from the equation of Hill (11) 
and,  in  contrast to the  models mentioned above, is  not  a 
molecular model when the Hill coefficient  nn is not an integer. 
It  gives  a  phenomenological description  of the  [3H]QNB 
binding if the competitor binding demonstrates cooperativity 
(phenomenological cooperativity model): 
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FIGURE  I  Fluorescence decrease in a cell suspension loaded with 
CTC after stepwise stimulation by acetylcholine. Two consecutive 
stimulations adding up to the maximal inducible effect are shown. 
Total fluorescence changes (Alr~,  AIr2) were measured graphically 
as the difference between total fluorescence (IT) and fluorescence 
after stabilization (11). On-line plot of fluorescence intensity. 
Bmax' [3HQ] 
[R-aHQ]  =  Ko +  [3HQ] +  [A]"".Ko/K"  (12) 
(K' is a constant without physiological meaning.) 
RESULTS 
Tracing of Ca  2÷ Mobilization by CTC 
Fluorescence 
Cell suspensions loaded with CTC responded to the addi- 
tion of muscarinic cholinergic agonists with a  fluorescence 
decrease. This decrease indicates receptor-mediated  Ca  2+ mo- 
bilization and was  documented by continuous tracing in a 
spectrofluorometer  (Fig. 1). The fluorescence intensity is given 
in arbitrary units which depend on the actual setting of the 
spectrofluorometer. After addition of a submaximal dose of 
acetylcholine, total fluorescence (IT,) decreased within 4 min 
and stabilized on a  new plateau (It). IT, and I, were deter- 
mined graphically. The fluorescence decrease was  obtained 
by subtraction (A/T, = L  -- IT,). A second stimulation with a 
higher dose resulted in a further decline of fluorescence inten- 
sity (AIT2 in Fig.  1). After correction of  the dilution effect, the 
drug-induced component of the total  fluorescence changes 
(A/b,o0 was  standardized according to Eq.  4.  The maximal 
drug-induced  fluorescence decrease was  ~15%  of cellular 
fluorescence. 
Reproducibility 
The standardized fluorescence changes A/~,~d (Eq. 4) mea- 
sured in  different matched probes of one cell preparation 
(intra-assay  variability)  showed  a  variability  of cv  =  7% 
(n = 5; cv: coefficient  of  variation). The 2d~.d values obtained 
in different preparations of  comparable cell suspension (inter- 
assay variability) revealed a variability of cv =  12% (n = 49). 
The respective variabilities of the A/hip, values (Eq.  2) that 
were not standardized amounted to cv =  12%  (intra-assay 
variability) and cv =  38% (inter-assay variability). 
Establishment of Dose-Response Curves 
In the experiment of Fig.  1, a first addition of a relatively 
low concentration of acetylcholine resulted in a submaximal 
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choline  triggered  an  additional  effect.  After  the  maximal 
response had been reached, no further reaction was obtained. 
The dose-response curves described below were established 
by evaluation  of such  stepwise  stimulation.  Three  to  four 
additive stimulations could be measured in one probe because 
the plateau phase lasted only for ~20 min. If more gradations 
were necessary for a dose-response curve, matched cell sus- 
pensions were used. 
Reversibility of Reaction 
The fluorescence decrease triggered by muscarinic agonists 
was found to be reversed by the addition of an antagonistic 
drug.  In the  experiment shown in  Fig.  2,  after addition  of 
acetylcholine, the fluorescence was reversed by pilocarpine. 
As described before (4),  in cell suspensions from chick limb 
bud and from whole chick embryos, pilocarpine antagonizes 
the acetylcholine-induced Ca  2+ movement. Reaction and re- 
versal can be repeated several times with increasing concen- 
tration ofagonists and antagonists. In this respect, pilocarpine 
and  atropine  show  the  same  antagonistic  behavior.  After 
repetitive stimulation and reversal, the sum of the responses 
to  agonists  surmounted  the  maximal  response  obtainable 
without antagonistic reversal. The experiment demonstrated 
reversibility of ligand binding and repeatability of the drug 
effects. 
In contrast to the fluorescence decrease which lasted 4 rain, 
reversal  of the  fluorescence  decrease  by  antagonistic  sub- 
stances took  ~8  rain.  In the  experiment shown in  Fig.  2, 
pilocarpine was used as the antagonistic substance because its 
dissociation from the receptor is fast enough to allow further 
stimulation. For the third reversal (Fig. 2), atropine had to be 
used, since it is technically impossible to obtain the necessary 
excess of pilocarpine. 
Dose-Response Curves 
Fig. 3 shows dose-response curves of the agonists acetylcho- 
line and carbachol and of the partial agonist bethanechol. The 
standardized effect Alst~,d is depicted against the agonist con- 
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FIGURE  2  Repetitive  stimulation  and  reversion  of  fluorescence 
change. After acetylcholine stimulation the effect was antagonized 
by a relative excess of pilocarpine, The reaction cycle consisting of 
agonistic stimulation and antagonistic reversal of reaction was trig- 
gered a second time with  higher concentrations of acetylcholine 
and pilocarpine. The cycle was repeated a third time with a maximal 
dose of acetylcholine and reversal by the antagonist atropine. 
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FIGURE  3  Dose-response curves for  acetylcholine (acetylch) car- 
bachol,  and  bethanechol  fitted  according to  Eq.  7.  Bethanechol 
triggered only one-third  of the  maximal inducible  response.  Pre- 
vious addition of the reversible competitive antagonist pilocarpine 
(pilot) shifted the dose-response curve of acetylcholine to the right. 
STAND, standard. L, liter. 
TABLE  I 
Parameters of Dose-Response Curves 
EDso (Confi-  Effect  relative to 
Substance  dence limits)  n  acetylcholine*  n 
Acetylcholine 
Carbachol 
Bethanechol 
Oxotremorine 
pilocarpine 
(mollliter) 
3.4 X  10  -6  9  100% by 
(2.7-4.3 x  10-6)  )  definition 
2.7 x  10  -5  5  92 4- 26% 
(1.8-3.9 x  10-s) * 
4.8 x  10  -4s  1  23 4- 9% 
No reaction 
Parameters are fitted according to Eq. 7 assuming the simple law of mass 
action between receptor-mediated effect and agonist concentration using 
the BMDP software (see Data Analysis). The results are expressed as mean 
4- SD of several dose-response  experiments. 
" Expressed  as percentage of acetylcholine effect + SD. 
* Confidence limits are unsymmetric because means and standard deviations 
are calculated from logarithms of EDso  values. 
t ED5o is fitted from the dose-response curve shown in Fig. 3. Therefore no 
confidence limits are given, 
centration. The effects were measured as indicated in Fig.  1 
and standardized according to Eq. 4. 
With acetylcholine and carbachol a full effect was obtained, 
whereas  bethanechol  triggered  only  about  one  fourth  the 
maximal response obtainable with the full  agonists. Table I 
summarizes the data of several experiments in which dose- 
response curves were established. The EDso of carbachol was 
one order of magnitude higher than that of acetylcholine. The 
partial agonist bethanechol had the highest EDso. As outlined 
in the previous study, oxotremorine and pilocarpine showed 
no agonistic effect in this system (4). 
Influence of Reversible Competitive Antagonists 
on Dose-Response Curves 
Presence of the  antagonistic substance pilocarpine in the 
assay reduced the sensitivity of acetylcholine: Higher concen- 
trations of agonist had to be used to achieve the same effect 
and the dose-response curve of acetylcholine was shifted to 
the right (Fig. 3). 
From such measurements we were able to determine the KI 
values of the antagonists in question according to Eq. 8. The 
results for five antagonists are shown in Table II. Because of the antagonistic component of the partial agonist bethane- 
chol, the  K~  of this  substance could be determined in  the 
competitive assay for antagonists. The EDso value of betha- 
nechol as agonist and its K~ value as antagonist showed similar 
values (4.8 x  10  -4 M and 1.9 ×  10  -4 M). 
According to Furchgott (I0,  12), there are two groups of 
competitive antagonists: "reversible" and "irreversible." The 
results described above indicate that atropine, pirenzepine, 
oxotremorine, pilocarpine, ievetimide, and bethanechol be- 
have as reversible competitive antagonists in our system. 
Influence of Irreversible Competitive Antagonists 
As shown in Fig.  4,  preincubation of the cell suspension 
with increasing concentrations of QNB led to a reduction of 
the maximum effect inducible by acetylcholine. 1 ×  10  -~° M 
QNB reduced the maximal response to 50%.  The EDso of 
acetylcholine within the dose-response curves did not change. 
Therefore, in  this  context, the  antagonist  QNB  has  to  be 
classified as slowly dissociating and thus a practically irrever- 
sible competitive antagonist (10, 12). The antagonist dexetim- 
ide showed the same behavior, having no effect on the EDso 
of agonists  but  reducing  the  maximum  effect  (data  not 
shown). 
Binding Studies with [3H]QNB 
To correlate the effects of muscarinic drugs on Ca  2+ mobi- 
TABLE  II 
K~ Values of Antagonists 
K~ values 
Substance  Mean*  Range 
No. of in- 
depend- 
ent deter- 
minations 
molfliter 
Atropine  0.8 x  10  -9  0.5-1.3  x  10  -~  7 
Pirenzepine  1.6 x  10  -7  1.3-2.0  x  10  -7  2 
Oxotremorine  1.4 x  10  -6  1.2-1.7  x  10  -6  3 
Pilocarpine  5.0 x  10  -6  3.6-8.2  x  10  -6  5 
Levetimide  8.8 x  10  -6  5.4-15  x  10  -6  3 
Bethanechol  1.9 x  10  -4  1.1-5.3  x  10  -4  4 
The  K~ value  is a measure  of the antagonistic  potency of the  respective 
reversible  competitive antagonist.  K~ values  were calculated  according to 
Eq. 8, where the EDso  is the value of the agonist and the ED'~ is the value 
of the dose-response  curve after additions of antagonist  are inserted. 
* Mean values calculated  as means of log K~. 
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FIGURI~  4  Dose-response  curve  of  acetyIcholine  (A.CH.)  after 
equilibration  with  various  concentrations  of the antagonist  QNB. 
Increasing QNB  concentrations  led to a  reduction  of the maximal 
inducible effect. STAND, standard.  L, liter. 
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FIGURE  5  Chick  embryo cells were incubated with increasing  con- 
centrations  of the ligand [3H]QNB. In incubation 2 (incub. 2) specific 
binding was suppressed by an excess of radioinert atropine. Non- 
specific (nonspec.)  binding increased  proportionally with [3H]QNB 
concentration. In incubation I (incub. l), in addition, specific (spec.) 
binding occurred. Specific binding was calculated from the differ- 
ence of both curves. L, liter. 
lization with occupancy of the muscarinic receptor, we per- 
formed binding studies in cell suspensions. The cell suspen- 
sions of whole chick embryos were identical to those used for 
CTC fluorescence measurements. 
The cell suspensions were incubated with the specific mus- 
carinic ligand  [3H]QNB  for 90  min at 37"C.  Separation of 
cell-bound and  free radioactivity was  performed by  rapid 
centrifugation. To discriminate specific and nonspecific bind- 
ing,  we  performed a  second incubation with  an  excess  of 
unlabeled atropine. Specific binding of [3H]QNB to the cells 
was calculated according to Eq. 6. The intra-assay variability 
of the Dcor~values  was determined as cv =  3.4% (n =  12). 
Saturation Studies 
Fig.  5 shows  the determination of specific  binding.  The 
curve marked by solid squares gives the total bound radio- 
activity in  incubation  1 with  increasing concentrations of 
[3H]QNB. The curve marked by solid circles gives the linear 
increase of nonspecific binding as determined in incubation 
2. The specifically bound radioactivity (open triangles)  shows 
saturation characteristics. 
In Fig. 6, binding data of three saturation experiments are 
transformed and depicted as Scatchard plots (i 3). Intersection 
with the abscissa indicates specific binding capacity Bma~ and 
the slope indicates the affinity of the specific binding sites for 
[3H]QNB. All three plots are linear, which indicates a single 
class of noninteracting specific binding sites. Parameter esti- 
mates are given in Table III. 
The first  saturation experiment of Fig.  6  was  performed 
with a  cell  suspension  from limb buds that at stage  23/24 
consists only of undifferentiated cells; the other two experi- 
ments used cells of whole chick embryos of the same stage. 
In the experiment with limb buds, a lower cell concentration 
was obtained leading to a lower Bmax value. In addition, the 
number of binding sites per cell in limb bud was lower than 
in cell suspensions of whole chick embryos (Table III). The 
essential  feature of the receptor, its affinity, was identical in 
both preparations. 
Competition Studies 
In the competition studies the radioinert ligands in question 
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tions the remaining specific binding of [3H]QNB was calcu- 
lated. In the resulting competition curves (Fig. 7), three groups 
of ligands could be distinguished.  The first group comprises 
the  antagonists  QNB,  dexetimide,  and  atropine.  The  IDso 
(concentration of competitor that reduces specific [aH]QNB 
binding to 50%) values were 10  -l°,  l0  -9, and l0  -8 M, respec- 
tively.  The  second group  comprises the  antagonistic drugs 
pirenzepine, oxotremorine, levetimide (not depicted in Fig. 
7), and pilocarpine and the partial agonist bethanechol. The 
respective IDso values ranged between l0  -6 and 2 x  l0  -3 M. 
The third group comprises the fully efficacious agonists ace- 
tylcholine and  carbachol.  The  IDso  of the  agonists ranged 
between 2  x  l0  -4 and 2  x  l0  -3 M.  In contrast to the steep 
competition curves of the antagonists, those of the agonists 
were flat. 
Tables IV + V give the parameter estimates fitted according 
to the one binding-site model (Eq. 10), the phenomenological 
cooperativity model (Eq. 12), and the two binding-sites model 
(Eq.  I l) as described in Data Analysis. 
For antagonists, the one-site model gave a good fit which 
was  not  improved by the  phenomenological cooperativity 
model, as indicated by the MSE (Table IV). For agonists, the 
fit was considerably improved. Therefore, for agonists the two 
binding-sites model was applied (Table V). 
DISCUSSION 
In this paper we describe a muscarinic cholinergic receptor in 
cell suspensions of the 31/2-d chick embryo (stage 23/24). We 
found that stimulation of the receptor leads to intracellular 
2- 
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FIGURE  6  Scatchard transformation of three saturation studies re- 
sults  in linear plots. Although the number of binding sites in limb 
bud cells was less than in cell suspensions of whole embryos, the 
receptor affinities  were the  same, as  indicated  by similar slopes. 
Spec., specifically. L, liter. 
Ca  2+  mobilization  which  is  visualized  fluorometrically  by 
changes of CTC fluorescence. 
In a previous study (1) we have shown that the receptor is 
present in the undifferentiated limb bud of the same stage. 
From our histochemical studies we know that in the chick 
embryo stage 23/24, a large number of undifferentiated cells 
express embryonic cholinesterase correlated to phases of mor- 
phogenesis (2). We therefore assume that the observations in 
cells  of whole  embryos reflect reactions of the  muscarinic 
receptor on undifferentiated cells. 
Fluorometric  Measurements 
The decrease of CTC fluorescence intensity after stimula- 
tion  reflects intracellular Ca  2+ mobilization (4-6).  It is  un- 
likely that in our experiments extracellular Ca  ++ is involved 
because over a wide range of Ca  2+ concentrations (0-4 mM) 
the reaction is independent  of the actual extraceIlular Ca  2+ 
level.  If the cells are stimulated in Ca2+-free solution in the 
presence of 0.1 mM EGTA, the reaction remains unchanged, 
only the repetitivity of the reaction is restricted.  If cells are 
kept in Ca2+-free medium for hours they lose their ability to 
react  presumably  owing  to  depletion  of intracellular  Ca  2+ 
(unpublished results). 
In the present experiments the CTC assay was standardized 
for quantitative evaluation so that dose-response curves and 
EDso values could be established. The pharmacologic profile 
of the  embryonic muscarinic receptor was  found  to be  as 
follows: Acetylcholine and carbachol are full agonists whereas 
bethanechol is a partial agonist (23% of maximal effect). The 
classical agonists pilocarpine and oxotremorine do not trigger 
Ca  2+ mobilization in embryonic cells. 
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CONCENTRATION OF  COMPETITOR  .(MOL I L) 
FIGURE  7  In the competition studies  with [3H]QNB, the respective 
muscarinic ligand was added to the incubations in increasing  con- 
centrations. Maximal binding was determined without competitor 
and  nonspecific  binding  in  presence of  1 ~M  atropine.  Only the 
values  in  the  respective saturation  range are  shown.  Curves  are 
fitted as outlined in Data Analysis.  Parameters are given in Tables 
IV and V. L, liter. 
TABLE III 
Binding Parameters of Specific [3H]QNB  Binding Sites 
No. of data  Binding sites per 
Material  Cell concentration  pairs  KD  Bmax  cell 
cells/ml  I0  -~2 mol/liter 
Chick limb bud  6.4 x  106  6  95 _+ 7*  24.2 +  0.5*  2,300 
Whole embryo  9.5 x  106  13  107_ 8*  59.2 +_ 1.4"  3,700 
Whole embryo  9.0 x  106  19  94 _  6*  52.8 _+ 1.0"  3,500 
Parameters were  fitted  according  to  Eq.  9  (see  Data  Analysis) with  the  BMDP software  (8MDP  Statistical  Software,  University of California,  1981) on  the 
UNIVAC  1100/80 (Rechenzentrum der Universit~it T0bingen). 
* Asymptotic standard deviation (compare  BMDP manual, 1981). 
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Parameters According to the One-siteModel and the PhenomenologicalCooperativityModel 
Substance 
One-site model  Phenomenological  cooperativity model 
KA 
Confidence limits)  MSE  nH+  S*  MSE 
QNB 
Dexetimide 
Atropine 
Pirenzepine 
Oxotremorine 
Levetimide 
Pilocarpine 
Acetylcholine  1 
Acetylcholine  2 
Carbachol 
Bethanechol 
(molfliter) 
2.9 X  10  -11  0.89  0.98 ±  0.15  1.0 
2.4-3.4  X  10  -u) 
3.6 X  10  -1°  1.3  0.63 ±  0.08  0.5 
2.8-4.7  X  10  -1°) 
1.7 X  10  -9  1.4  0.79 ±  0.12  1.2 
1.4-2.1  X  10  -9  ) 
1.1  X  10  -r  3.9  1.31  +  0.39  4.0 
0.8-1.5  X  10  -7  ) 
1.8 X  10  -6  0.4  0.95 ±  0.08  0.4 
1.6-1.9  X  10  -6  ) 
5.4 ×  10  -6  1.6  0.76 ±  0.16  1.5 
4.2-7.0  X  10  -6) 
8.8 X  10  -6  2.8  0.68 +  0.07  1.3 
7.2-11.0  X  10  -6) 
3.5 X  10  -5  5.1  0.41  ±  0.05  0.9 
2.2-5.4  X  10  -s) 
2.7 X  10  -s  8.3  0.39 ±  0.06  1.7 
1.7-4.1  X  10  -s) 
2.7 X  10  -4  8.1  0.41  -+ 0.07  1.6 
1.6-4.3  X  10  -4) 
4.6 X  10  -4  2.0  0.65 ±  0.09  1.1 
(3.5-6.1  X  10  -4) 
Cell suspensions (5-9 ×  10  ° cells/ml; B~  =  30-60 pM) were incubated with  [3HJQNB (0.4 nM) in the presence of competitors at various concentrations as 
shown in Fig. 7. For acetylcholine, two independent experiments are shown. Dissociation constants were fitted as logarithms. Confidence limits were calculated 
from the asymptotic standard deviations (s') of the logarithms and, therefore, unsymmetric intervals are given. Parameter values of the one-site model (Eq. 10) 
and the phenomenological cooperativity model (Hill) (Eq. 12) were fitted, as outlined in Data Analysis,  to the data of competition experiments shown in Fig. 7. 
For antagonistic substances,  the one-site model gave a good fit which  was not improved  by the  pbenomenological cooperativity model.  For the agonists 
acetylcholine and carbachol, the goodness of fit was clearly improved, as indicated by distinctly reduced MSE. K^, dissociation constant of the one-site model; 
nil, Hill coefficient. 
TAI3LE V 
Parameters According to the Two-sites Model 
RH -- s*  KH  RL ±  s*  KL 
Substance  (%B,,~)  (Confidence limits)  (%Bmax)  (Confidence limits)  MSE 
pmol[liter  tool/liter  pmol/liter  molfliter 
Acetylcholine  1  15.3 ±  1.6  3.9 x  10  -6  13.8 ±  1.7  0.95 x  10  -3  1.1 
(53)  (2.6-5.9  x  10  -6)  (47)  (0.5-1.7  x  10  -3) 
Acetylcholine  2  20.9 ±  1.9  4.4 ×  10  -6  19.4 +  2.5  1.3 x  10  -3  1.6 
(52)  (3.1-6.3  x  10  -6)  (48)  (0.7-2.1  x  10  -~) 
Carbachol  14.6 ±  2.0  1.7 x  10  -5  18.4 ±  2.0  2.6 x  10  -3  1.1 
(44)  (1.1-2.6 x  10  -5)  (56)  (1.6-4.1  x  10  -5) 
Bethanechol  9.1  _+ 3.2  2.6 ×  10  -5  19.9 ±  3.1  1.3 ×  10  -3  0.9 
(31)  (1.0-6.9  x  10  -5)  (69)  (0.8-2.0 x  10  -3) 
Cell suspensions (5-9 x  106 cells/ml; B~, --- 30-60 pM) were incubated with  [3H]QNB (0.4 riM) in the presence of competitors at various concentrations as 
shown in Fig. 7. For acetylcholine, two independent experiments are shown. Dissociation constants were fitted as logarithms. Confidence limits were calculated 
from the asymptotic standard deviations (s*) of the logarithms, and thus unsymmetric intervals are given. Parameter values of the two-sites model (Eq. 11) were 
fitted for the agonists.  The two-sites model gave a better explanation for binding of agonists.  RH and KH, receptor capacity and dissociation constant of high 
affinity binding sites;  Rt and KL, receptor capacity and dissociation constant of low-affinity binding sites;  RH and RL are given in per~:entage of total binding 
capacity (% B~-~). 
When  antagonists  were  added  before  stimulation  by  an 
agonist, two distinct patterns were observed. The first class of 
antagonists shifted the dose-response curve into higher con- 
centration ranges without lowering the maximal effect and 
without affecting the shape of the curve (Fig.  3). According 
to  Furchgott  (I0,  12),  these  compounds  are  classified  as 
reversible competitive antagonists. The classical muscarinic 
antagonists atropine,  pirenzepine, and levetimide belong to 
this group as well as the classical muscarinic agonists oxotre- 
morine and pilocarpine. The partial agonist bethanechol also 
shifts the dose-response curve of a  full agonist to the fight. 
From the shift of dose-response curves,  we determined the 
inhibitory constants (K~ values; Table II). 
The  second  class  of  antagonists,  comprising  QNB  and 
dexetimide,  led  to dose-dependent  diminution  of maximal 
effect, the EDso remaining nearly unchanged (Fig. 4). Accord- 
ing to Furchgott (10,  12) these compounds are classified as 
irreversible competitive antagonists. The term "irreversible" 
in this context states that the compounds of this group dis- 
sociate so slowly from the receptor sites that during the time 
course in which the biological effect is observed (20 min), the 
blockade seems to be irreversible. In our system, the half-life 
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FIGURE  8  The fraction of unblocked binding sites at a given QNB 
concentration (abscissa) is correlated with the maximal effect ob- 
tained by saturating agonist concentrations at the same QNB con- 
centration (ordinate). The fluorescence changes were obtained from 
the dose-response curves after preincubation with various concen- 
trations of QNI3 (Fig. 4). The fraction of receptor sites available at 
the respective QNB concentration was calculated from the disso- 
ciation constant derived from the  saturation studies  (Fig. 6  and 
Table III). 
of  the QNB-receptor complex (at 37"C) is 4-5 h (unpublished 
data). 
When added after stimulation, all antagonistic compounds 
including oxotremorine and pilocarpine were capable of re- 
versing the agonist-induced Ca  2+ mobilization. Fig.  2 illus- 
trates that stimulation by agonist and reversal by a reversible 
competitive antagonist could be repeated several times in the 
same cell  suspension.  The reversibility and  repeatability of 
the effects are strong arguments for the biological character 
of the reaction. 
Binding Studies 
In  parallel to  the  fluorometric measurements, we deter- 
mined the  muscarinic binding sites  using  [3H]QNB  as the 
ligand.  Separation of bound and unbound radioactivity by 
centrifugation maintained the equilibrium and thus yielded 
unbiased values as compared with a filter assay. By measuring 
unbound  [~H]QNB  in  every incubation,  we  were  able  to 
correct  for  errors  due  to  differing  amounts  of unbound 
[3H]QNB in the individual incubations. This avoids system- 
atic errors in the calculation of specific binding (Eq. 6) and 
in the parameter fits. 
The Scatchard plots indicate the existence of a single pop- 
ulation of noninteracting specific binding sites for [3H]QNB 
(Fig. 6 and Table III). In the competition studies the antago- 
nists showed steep sigmoid curves whereas for the agonists 
acetylcholine and  carbachol  flat  competition  curves  were 
obtained  (Fig.  7).  The  binding  data  of antagonistic  com- 
pounds are in agreement with the assumption of  a single class 
of binding sites (one-site model, Table IV). The observation 
of  a single class of  noncooperating binding sites for muscarinic 
antagonists  is  in  accordance  with  results  of Birdsall  and 
Hulme ( 14, 15). For the agonists acetylcholine and carbachol, 
the phenomenological cooperativity model resulted in a dis- 
tinctly better fit than the one-site model (Table IV). The Hill 
coefficients between 0.38 and 0.41  indicate negative cooper- 
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ativity of agonist binding. This is a general finding in agonist 
binding of muscarinic receptors which is usually explained by 
assuming at least two distinct classes of  noninteracting binding 
sites with different affinities for agonists (16,  17). Table V 
gives the fitted parameter values if a two-sites  model is as- 
sumed. Our data don't allow for the extraction of a third class 
of"super high-affinity sites" as described in rat brain (16,  18). 
The binding data of the partial agonist bethanechol are ex- 
plained by both agonistic and antagonistic behavior (Fig.  7 
and Tables IV and V). 
Correlation of Ca  2+ Mobilization and 
Receptor Occupancy 
The K~ values of antagonists determined from the shift of 
dose-response curves (Table II) are in good agreement with 
the KD values calculated according to the one-site model (KA 
values Table IV).  In the fluorometric measurement, oxotre- 
morine and pilocarpine were observed to behave as antago- 
nists. In the binding studies they showed competition curves 
with  one  KD and  no  signs  of cooperativity. This  binding 
behavior is characteristic of antagonists. 
From the dose-response curves the EDso  of acetylcholine 
were quantitated as 3.4 × -6 M (Table I). This value is nearly 
equal to the Ko of the high-affinity site (KH in Table V) of the 
two-sites  model. The same holds true for the EDso and the 
KH value of the high-affinity binding site  of carbachol. We 
conclude that in chick embryo cells, the biological effect of 
Ca  2+ mobilization is triggered via the  high-affinity binding 
site.  Accordingly,  the  agonistic  component  of the  partial 
agonist bethanechol was expressed in the high-affinity binding 
site when competition data were fitted for the two-sites model 
(Table V). Declining pharmacological activities (Table I) cor- 
related with declining affinities of high-affinity binding sites 
(KH in Table V) and with declining ratios of high- to low- 
affinity binding sites  (Rn/RL  in  Table V). The dissociation 
constant  of the  low-affinity binding  sites  (KL in  Table V) 
remained nearly constant. Thus, biological activity seems to 
be independent of low-affinity binding sites. Correlation be- 
tween high-affinity muscarinic binding sites and Ca  2÷ influx 
into smooth muscle cells was described by Triggle (19). Other 
authors, however, relate biological responses to low-affinity 
muscarinic binding sites (17, 20-23). 
Fig.  8 correlates the maximal Ca  2÷ mobilization that can 
be induced in embryonic cells by muscarinic agonists  with 
the  fraction  of muscarinic  receptor  sites  occupied  by  an 
agonist.  The number of available receptor sites is varied by 
preincubation  with  the  irreversible  competitive antagonist 
QNB as shown in Fig. 4.  100% of the relative fluorescence 
change  was  obtained  without  QNB.  Gradual  blocking  of 
binding sites by QNB led to a proportional diminution of the 
biological effect that can be triggered by saturating concentra- 
tions of agonists.  The inducible Ca  2+ mobilization was pro- 
portional to the number of available binding sites. No spare 
receptors were present. 
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